Role of Mastectomy in Stage 4 Invasive Ductal Carcinoma
Treatment Framework for Stage IV Disease
- Stage IV breast cancer is classified as metastatic or recurrent carcinoma, where the focus shifts from locoregional control to systemic disease management, according to the National Comprehensive Cancer Network 1
- Systemic therapy constitutes the primary treatment modality for stage IV disease, as recommended by the European Society for Medical Oncology 2
- The goal is palliative control of distant metastases rather than cure, making aggressive locoregional surgery less relevant in most cases, as stated by the National Comprehensive Cancer Network 1
Surgical Considerations When Mastectomy Is Pursued
- Sentinel lymph node biopsy or low axillary sampling should be performed if mastectomy is undertaken, as staging information guides adjuvant therapy decisions, according to Praxis Medical Insights 3
Critical Decision Points
- Poor performance status or significant comorbidities are factors against mastectomy, as noted by the European Society for Medical Oncology 2
- Symptomatic primary tumor causing pain, bleeding, or ulceration requiring palliation may be a factor favoring consideration of mastectomy, as mentioned by the European Society for Medical Oncology 2